ClinicalTrials.Veeva

Menu

Nutritional Intervention and Outcomes in Elderly After Hip Fracture Surgery

P

Peking University

Status

Terminated

Conditions

Hip Fractures
Survival
Perioperative Outcomes
Malnutrition
Nutritional Intervention
Elderly Patients

Treatments

Dietary Supplement: Nutritional intervention group
Dietary Supplement: Control group

Study type

Interventional

Funder types

Other

Identifiers

NCT04451538
2019-322

Details and patient eligibility

About

Hip fracture is one of the most frequently occurred injury in the elderly and usually requires surgical treatment. Malnutrition is common in elderly patients with hip fracture and is associated with worse outcomes. This study is designed to test the hypothesize that, in elderly patients with malnutrition or at risk of malnutrition and scheduled for hip-fracture surgery, perioperative nutritional intervention may reduce early complications and improve long-term survival.

Full description

Elderly patients with hip fracture have a high rate of malnutrition. In a cohort study of hip fracture patients aged 70 years or older, 18.8% have malnutrition and 44.6% are at risk of malnutrition. Increasing evidence suggest that preoperative nutritional status has a significant impact on clinical outcomes of elderly patients following surgery. For example, preoperative malnutrition or risk of malnutrition is associated with increased delirium, increased non-delirium complications, prolonged hospital stay, high mortality, and even worse long-term survival after surgery. We speculate that perioperative nutritional intervention may reduce postoperative delirium and improve early and long-term clinical outcomes in elderly hip-fracture patients. The purpose of this study is to observe the effect of perioperative nutritional intervention on early postoperative delirium and complications as well as long-term survival in the patients with malnutrition or at risk of malnutrition who are scheduled for hip-fracture surgery.

Enrollment

30 patients

Sex

All

Ages

70+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥70 years old;
  • Hospitalized for hip fracture, scheduled to undergo hip-fracture surgery within 48 hours;
  • Classified as malnutrition or at risk of malnutrition according to the short form mini-nutrition assessment (MNA-SF);
  • Provide written informed consents.

Exclusion criteria

  • Pathological fracture;
  • History of schizophrenia, epilepsy, Parkinson's disease, or myasthenia gravis before surgery;
  • Unable to communicate due to coma, severe dementia, or language barrier;
  • Unable to eat due to any disease in the gastrointestinal system;
  • Severe hepatic dysfunction (Child-Pugh class C), renal failure (requirement of renal replacement therapy), respiratory failure (requirement of respiratory support), cardiac insufficiency (New York Heart Association classification ≥IV), or American Socisty of Anesthesiologists classification ≥IV;
  • Preexisting organ injury before surgery (delirium, acute kidney injury, myocardial injury, etc.);
  • Other conditions that are considered unsuitable for study participation.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

30 participants in 2 patient groups, including a placebo group

Nutritional intervention group
Experimental group
Description:
Supplemental nutritional support is provided in addition to normal diet during the perioperative period (five days from pre- to postoperative phase). For non-diabetic patients, ENSURE is provided (Abbott; 112.6 g \[12 spoon, 500 kcal\]/day, twice a day); for diabetic patients, GLUCERNA SR is provided (Abbott; 104 g \[12 spoon, 440 kcal\]/day, twice a day).
Treatment:
Dietary Supplement: Nutritional intervention group
Control group
Placebo Comparator group
Description:
Supplemental nutritional support is not provided in addition to normal diet during the perioperative period (five days from pre- to postoperative phase).
Treatment:
Dietary Supplement: Control group

Trial contacts and locations

3

Loading...

Central trial contact

Dong-Xin Wang, MD, PhD; Dong-Mei Ni, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems